Prazosin in the treatment of resistant arterial hypertension associated with nephropathy
Cuesta, V.; Cannata, J.; Herrera, J.; Maisueche, I.; Peral, V.; Redondo, C.
Revista Clinica Espanola 161(1): 37-39
1981
ISSN/ISBN: 0014-2565 PMID: 7255814 Document Number: 174930
Document emailed within 1 workday
Related Documents
Datcu, G.; Datcu, M.D.; Barna, S.; Cioară, O. 1988: The value of prazosin treatment in arterial hypertension Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 92(4): 751-754Luna, R.L. 1986: Prazosin in the initial treatment of arterial hypertension Arquivos Brasileiros de Cardiologia 47(2): 111-117
Labriola, S.; Di Benedetto, S.; Poggi, V.M. 1982: Prazosin: clinical use in the treatment of arterial hypertension and cardiac insufficiency La Clinica Terapeutica 101(3): 319-322
Forette, F.; Henry, J.F.; Hervy, M.P.; Henry-Amar, M.; Brugier, S. 1983: Treatment of arterial hypertension in aged subjects with an alpha-blocker: prazosin Therapie 38(4): 387-392
Metelitsa, V.I.; Filatova, N.P. 1991: The results of the comparative study of nadolol, propranolol, prazosin and hydrochlorothiazide in patients with arterial hypertension in a 12-month stepped-plan treatment (cooperative research). The Working Group of the Cooperative Program to Study New Preparations in the Prevention of Arterial Hypertension. I. The research protocol and results of monotherapy Terapevticheskii Arkhiv 63(8): 30-34
Shevchenko, O.S. 2003: Diagnostics and treatment of resistant arterial hypertension Likars'ka Sprava 2003(3-4): 11-14
Marinković, M.; Vrhovac, B.; Kuzmanić, D.; Radonić, M. 1979: Comparative study with prazosin, methyldopa and polythiazide in arterial hypertension International Journal of Clinical Pharmacology and Biopharmacy 17(1): 38-47
Krzesinski, J.M. 2009: How to manage an arterial hypertension resistant to drug treatment Revue Medicale de Liege 64(3): 171-175
Maggiore, Q.; Biagini, M.; Zoccali, C.; Misefari, M. 1975: Propranolol treatment of resistant arterial hypertension in patients on chronic dialysis Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 11: 222-228
Maciel, R.M.; Spritzer, N.; Spritzer, T.S.; Abichequer, M.B. 1981: Treatment of diuretic-resistant arterial hypertension - crossed comparative study of verapamil and clonidine Arquivos Brasileiros de Cardiologia 36(Suppl 1): 47-50
Sukhorukov, V.V.; Frolova, E.V.; Tereshina, O.V.; Krugomov, A.V.; Trofimov, S.I.; Goncharova, E.S. 2011: Endovascular treatment of a female patient with resistant arterial hypertension secondary to a renal artery aneurysm Angiologiia i Sosudistaia Khirurgiia 17(4): 49-52
Oliván, J.; Miranda, M.J.; Chozas, J.; Gras, B.X.; Garrido, M. 1985: Long-term efficacy of captopril in the treatment of moderate/intensive arterial hypertension resistant to 3 antihypertensive drugs Medicina Clinica 85(14): 571-574
Witkowski, A.; Januszewicz, A.; Imiela, J.; Narkiewicz, K.; Opolski, G.; Rowiński, O.; Sadowski, J.; Dudek, D.; Bryniarski, L.; Gil, R.J.; Adamczak, M.; Grajek, S.; Kądziela, J.; Prejbisz, A.; Nowicki, M. 2011: Catheter-based renal sympathetic denervation for the treatment of resistant arterial hypertension in Poland - experts consensus statement Kardiologia Polska 69(11): 1208-1211
Bugaeva, N.V.; Balkarov, I.M.; Kolodin, V.A. 1994: Urate nephropathy in patients with arterial hypertension Terapevticheskii Arkhiv 66(6): 30-32
Widimský, Jří. 2015: PATHWAY-2 Study: spironolactone vs placebo, bisoprolol and doxazosin to determine optimal treatment of resistant hypertension. Spironolactone high effective in lowering blood pressure in drug resistant hypertension Vnitrni Lekarstvi 61(12): 1067-1071
Ardashev, A.V.; Zhelyakov, E.G.; Zotova, I.V.; Konev, A.V.; Khimiy, O.V.; Staferov, A.V.; Knigin, A.V.; Kolesnikov, V.N.; Maskova, N.A.; Baykulova, M.K.; Belenkov, Y.N. 2017: Clinical Aspects of Interventional Treatment of a Patient with Atrial Fibrillation Combined with Resistant Arterial Hypertension by the Method of Radiofrequency Ablation in Renal Arteries and Left Atrium Kardiologiia 57(12): 90-96
Raimondi, C.; Castiglioni, A.; Allergri, L.; Bocchi, B.; Orsini, S.; Vinci, S.; Savazzi, G.M. 1990: The pathogenesis of arterial hypertension in diabetes mellitus and its role in nephropathy Recenti Progressi in Medicina 81(12): 782-787
Walker, R.G.; Whitworth, J.A.; Saines, D.; Kincaid-Smith, P. 1981: Prazosin. Long-term treatment of moderate and severe hypertension and lack of "tolerance" Medical Journal of Australia 2(3): 146-147
Knypl, K.; Brym, E.; Czerniewska, E.; Wocial, B.; Kuczyńska, K.; Chodakowska, J. 1991: Effect of long-term prazosin treatment on certain humoral and metabolic factors in patients with primary hypertension Polski Tygodnik Lekarski 46(1-3): 32-34
Kanatu, K. 1977: Clinical studies of hypertension in patients undergoing regular maintenance hemodialysis. 1) a comparison of hemodynamic data and plasma renin activity between responsive and resistant hypertension to regular dialysis alone. 2) Beta adrenergic blockade in resistant hypertension Nihon Jinzo Gakkai Shi 19(11): 871-881